Cite
HARVARD Citation
Batista, J. et al. (n.d.). The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial. Therapeutic advances in urology. pp. 167-179. [Online].